Astrana Health Gross Margin 2016-2025 | ASTH
Current and historical gross margin for Astrana Health (ASTH) over the last 10 years. The current gross profit margin for Astrana Health as of September 30, 2025 is %.
| Astrana Health Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $2.90B | $0.30B | 10.22% |
| 2025-06-30 | $2.42B | $0.27B | 11.24% |
| 2025-03-31 | $2.25B | $0.27B | 11.87% |
| 2024-12-31 | $2.03B | $0.27B | 13.27% |
| 2024-09-30 | $1.72B | $0.26B | 15.04% |
| 2024-06-30 | $1.59B | $0.26B | 16.28% |
| 2024-03-31 | $1.45B | $0.24B | 16.59% |
| 2023-12-31 | $1.39B | $0.22B | 15.51% |
| 2023-09-30 | $1.33B | $0.22B | 16.35% |
| 2023-06-30 | $1.30B | $0.22B | 16.98% |
| 2023-03-31 | $1.22B | $0.21B | 16.83% |
| 2022-12-31 | $1.14B | $0.20B | 17.48% |
| 2022-09-30 | $1.05B | $0.18B | 17.42% |
| 2022-06-30 | $0.96B | $0.19B | 19.48% |
| 2022-03-31 | $0.86B | $0.19B | 21.49% |
| 2021-12-31 | $0.77B | $0.18B | 22.87% |
| 2021-09-30 | $0.76B | $0.19B | 25.66% |
| 2021-06-30 | $0.71B | $0.17B | 24.26% |
| 2021-03-31 | $0.70B | $0.16B | 23.21% |
| 2020-12-31 | $0.69B | $0.15B | 21.54% |
| 2020-09-30 | $0.69B | $0.14B | 19.59% |
| 2020-06-30 | $0.67B | $0.10B | 15.34% |
| 2020-03-31 | $0.63B | $0.10B | 16.19% |
| 2019-12-31 | $0.56B | $0.09B | 16.58% |
| 2019-09-30 | $0.49B | $0.09B | 18.81% |
| 2019-06-30 | $0.50B | $0.14B | 27.40% |
| 2019-03-31 | $0.49B | $0.13B | 26.57% |
| 2018-12-31 | $0.52B | $0.16B | 30.33% |
| 2018-09-30 | $0.53B | $0.16B | 30.15% |
| 2018-06-30 | $0.46B | $0.12B | 26.08% |
| 2018-03-31 | $0.42B | $0.11B | 26.78% |
| 2017-12-31 | $0.38B | $0.10B | 26.11% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.057B | $2.035B |
| Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $34.042B | 17.17 |
| Quest Diagnostics (DGX) | United States | $23.013B | 21.00 |
| Elanco Animal Health (ELAN) | United States | $12.486B | 26.18 |
| Encompass Health (EHC) | United States | $11.082B | 20.17 |
| DaVita (DVA) | United States | $9.950B | 13.72 |
| Chemed (CHE) | United States | $6.703B | 23.54 |
| Option Care Health (OPCH) | United States | $5.622B | 23.93 |
| RadNet (RDNT) | United States | $5.365B | 183.00 |
| LifeStance Health (LFST) | United States | $2.735B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.103B | 21.72 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.657B | 20.87 |
| U.S Physical Therapy (USPH) | United States | $1.322B | 33.44 |
| Pennant (PNTG) | United States | $1.106B | 36.75 |
| Daxor (DXR) | United States | $0.062B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.038B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |